(Sharecast News) - Mathematical modelling and biostatistics firm Physiomics said on Wednesday that it had secured a new contract with long-standing client, Numab Therapeutics.
Physiomics said the project will use PK/PD modelling and simulation approaches to inform understanding and selection of appropriate clinical dosing for a first-in-human study for an antibody...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE